We are live on ! Find out more
CINC

CinCor Pharma, Inc. Common Stock
CINC

Delisted

CINC was delisted on the 23rd of February, 2023.

Back to rankings

86 hedge funds and large institutions have $1.21B invested in CinCor Pharma, Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 34 funds opening new positions, 38 increasing their positions, 12 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

580% more first-time investments, than exits

New positions opened: 34 | Existing positions closed: 5

217% more repeat investments, than reductions

Existing positions increased: 38 | Existing positions reduced: 12

104% more capital invested

Capital invested by funds: $596M → $1.21B (+$617M)

51% more funds holding

Funds holding: 57 → 86 (+29)

0% more funds holding in top 10

Funds holding in top 10: 5 → 5 (0)

83% less call options, than puts

Call options by funds: $617K | Put options by funds: $3.69M

Holders
86
Holders Change
+29
Holders Change %
+50.88%
% of All Funds
1.48%
Holding in Top 10
5
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.09%
New
34
Increased
38
Reduced
12
Closed
5
Calls
$617K
Puts
$3.69M
Net Calls
-$3.07M
Net Calls Change
-$3.07M

Top Buyers

Rank Fund Capital Flow
1
PA
Perceptive Advisors
New York
+$27.9M
2
BBA
Baker Bros. Advisors
New York
+$22.8M
3
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$21.6M
4
5VM
5AM Venture Management
California
+$17M
5
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$16.9M

Top Sellers

Rank Fund Capital Flow
1
SCV
Sands Capital Ventures
Virginia
-$17.9M
2
OFM
Omega Fund Management
Massachusetts
-$11.5M
3
GPP
Great Point Partners
Connecticut
-$10.4M
4
BI
BVF Inc
California
-$9.38M
5
VP
venBio Partners
California
-$7.99M
Name Holding Trade Value Shares
Change 		Change in
Stake
Walleye Capital
26
Walleye Capital
New York
$4.15M +$2.74M +97,003 +331%
WP
27
Woodline Partners
California
$4.1M +$3.53M +125,050 New
SFM
28
Sphera Funds Management
Israel
$3.9M +$3.36M +118,950 New
N
29
Nuveen
North Carolina
$2.82M +$969K +34,277 +66%
Ensign Peak Advisors
30
Ensign Peak Advisors
Utah
$2.58M +$2.22M +78,480 New
Morgan Stanley
31
Morgan Stanley
New York
$2.52M +$1.52M +53,667 +232%
Bank of New York Mellon
32
Bank of New York Mellon
New York
$2.39M +$1.08M +38,067 +109%
Goldman Sachs
33
Goldman Sachs
New York
$2.26M +$1.64M +58,082 +541%
EI
34
EAM Investors
California
$2.1M +$1.8M +63,839 New
IHAM
35
Integral Health Asset Management
New York
$1.64M +$233K +8,252 +20%
TD Asset Management
36
TD Asset Management
Ontario, Canada
$1.49M -$63.2K -2,235 -4%
IC
37
Ikarian Capital
Texas
$1.48M +$1.27M +45,100 New
CS
38
Candriam SCA
Luxembourg
$1.48M +$1.27M +45,000 New
Citadel Advisors
39
Citadel Advisors
Florida
$1.46M +$1.25M +44,398 New
EGI
40
EAM Global Investors
California
$1.4M +$1.2M +42,629 New
Manulife (Manufacturers Life Insurance)
41
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$1.39M +$4.58K +162 +0.4%
Swiss National Bank
42
Swiss National Bank
Switzerland
$1.32M +$257K +9,100 +29%
MIM
43
Monashee Investment Management
Massachusetts
$985K +$848K +30,000 New
RhumbLine Advisers
44
RhumbLine Advisers
Massachusetts
$906K +$241K +8,511 +45%
Belvedere Trading
45
Belvedere Trading
Illinois
$890K +$769K +27,218 New
UBS Group
46
UBS Group
Switzerland
$753K +$623K +22,052 +2,529%
California State Teachers Retirement System (CalSTRS)
47
California State Teachers Retirement System (CalSTRS)
California
$744K +$160K +5,657 +33%
Tudor Investment Corp
48
Tudor Investment Corp
Connecticut
$716K +$616K +21,805 New
SGM
49
Seven Grand Managers
New York
$656K +$565K +20,000 New
State of Wisconsin Investment Board
50
State of Wisconsin Investment Board
Wisconsin
$570K +$491K +17,373 New
1
2
3 4

CINC Hedge Fund Activity: Q3 2022 in Review

86 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in CinCor Pharma, Inc. Common Stock (CINC) for Q3 2022, worth a combined $1.21B — up 104% from $596M a quarter earlier.

Buyers outnumbered sellers: 34 funds opened new CINC positions and 5 closed out — a net gain of 29 holders — while 38 added to existing stakes and 12 trimmed.

The largest buyer was Perceptive Advisors, adding an estimated $27.9M. The largest seller was Sands Capital Ventures, exiting entirely with an estimated $17.9M sold.

  • 86 institutional investors held CinCor Pharma, Inc. Common Stock (CINC) as of Q3 2022, up from 57 in Q2 2022.
  • Funds reported $1.21B of CinCor Pharma, Inc. Common Stock stock for Q3 2022, up 104% quarter-over-quarter.
  • 34 funds opened new CinCor Pharma, Inc. Common Stock positions in Q3 2022 and 5 closed out, a net change of +29 holders.
  • The largest CinCor Pharma, Inc. Common Stock buyer in Q3 2022 was Perceptive Advisors, an estimated $27.9M added.
  • The largest CinCor Pharma, Inc. Common Stock seller in Q3 2022 was Sands Capital Ventures, an estimated $17.9M sold.

Based on aggregated 13F filings for Q3 2022.